SCHEMBL4902844

SCHEMBL4902844

COC(=O)c1ncccc1Oc1ncc(Cl)cc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
CYP3A4 P08684 3/20 0.42
CCR2 P41597 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CCR4 P51679 2/20 0.42
ABL1 P00519 1/20 0.42
GRM4 Q14833 3/20 0.41
CYP1A2 P05177 2/20 0.41
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
CYP2D6 P10635 1/20 0.39
CCR5 P51681 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
CFTR P13569 1/20 0.36
MAP2K1 Q02750 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4912893 0.82 ALDH1A1 (0.51) CYP3A4CCR2CYP2C9CYP2C19CCR4
SCHEMBL4909567 0.79 CYP3A4 (0.41) CYP3A4CCR2CYP2C9CYP2C19CCR4
SCHEMBL4909376 0.79 CCR2 (0.49) CYP3A4CCR2CYP2C19ABL1CYP1A2
SCHEMBL4910281 0.78 CCR2 (0.53) L3MBTL1CYP3A4CCR2CYP2C9CYP2C19
SCHEMBL4909330 0.76 ALDH1A1 (0.48) L3MBTL1CCR2CYP2C9ABL1ALDH1A1
SCHEMBL4910594 0.76 CCR2 (0.77) CYP3A4CCR2CYP2C9CYP2C19CCR4
SCHEMBL4911339 0.76 L3MBTL1 (0.54) L3MBTL1CCR2ABL1PTGER4
SCHEMBL4772221 0.75 ABL1 (0.51) L3MBTL1ABL1ALDH1A1KDM4EGLA
SCHEMBL14006344 0.74 CCR2 (0.55) CYP3A4CCR2CYP2C9CYP2C19CCR4
SCHEMBL4911233 0.73 ALOX5AP (0.38) L3MBTL1CYP3A4CCR2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
WO-2007067875-A2 PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMTED (GB) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 L3MBTL1 4868/4885CYP3A4 1414/4885CCR2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.